Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
about
Patient Participation and the Use of Ehealth Tools for PharmacoviliganceAdverse Drug Reaction Identification and Extraction in Social Media: A Scoping ReviewViews of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature reviewDesigning adverse event forms for real-world reporting: participatory research in UgandaMedication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction ProfileFirst French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs.Protocol for the New Medicine Service Study: a randomized controlled trial and economic evaluation with qualitative appraisal comparing the effectiveness and cost effectiveness of the New Medicine Service in community pharmacies in EnglandvigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance.Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.Need for involving consumers in Nepal's pharmacovigilance systemKnowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania.Side effects of antineoplastic and immunomodulating medications reported by European consumers.Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation.Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer associationPerceived adverse drug reactions among non-institutionalized children and adolescents in Germany.Information about adverse drug reactions reported in children: a qualitative review of empirical studiesMotives for reporting adverse drug reactions by patient-reporters in the Netherlands.Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer associationConstruct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population.Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan.Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis.The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.Predicting adverse drug events from personal health messages.Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer OrganizationAdverse drug reactions--no farewell to harms.The value of patient reporting to the pharmacovigilance system: a systematic review.Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.A Review of Pharmacovigilance.Profile of rheumatology patients willing to report adverse drug reactions: bias from selective reportingSpontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.What can we learn from parents about enhancing participation in pharmacovigilance?An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia.
P2860
Q26752684-67A6F82B-6897-4083-B72E-4410A46FFC5BQ26824283-BB227291-0368-4E38-93E9-545E476D562AQ27008494-EDB51D92-D064-4952-A40D-33C3486B6084Q28481812-74706574-FF82-44DC-871D-9A2861C87B78Q28538501-384D5DDC-5F17-44FF-81CF-98D05ADC3AF0Q30421150-AC1AB49E-0BD4-4C81-81D4-1A2D2A9D24F4Q30583850-0CB430AE-39B8-4376-8B4E-189DADC9A441Q30596917-33C47DA7-B636-4FB3-97C7-80F07608347CQ30716859-D59C654B-9D54-481C-8768-E0E85ECCED7FQ30831823-2AA1997A-67B1-4621-8DF1-537A18ABEE95Q30844578-3DB15511-0248-4C04-B9B2-92D57491CDA8Q33492598-B22AB51B-997B-4CE1-BE2F-06F7C24AE95EQ33565507-AF727227-70DF-4181-BD2A-3C5778E52B71Q33824021-A9EFA0C6-D13B-412D-9AD2-4CC1A14EF3C0Q33827959-725BFF8A-7E04-4CBC-A6DD-93B0923A877EQ33932158-668EDDE7-A200-4BEA-B733-5079CAEF28BDQ34033938-9ACAACEB-4167-44E3-8380-8DD45566541BQ34057639-96E6916B-F5F8-4D91-A1E2-93938C30F5E6Q34174922-14B1BB37-DB6F-4585-9F48-EA8FAB82ACE7Q34180437-73944D93-8D43-4E4D-82D8-BD902EFD6C15Q34213612-3583BCA9-C484-4C65-9809-BD6D86591256Q34519989-7EBCE0DC-6242-409C-ABBD-541830F5FE2FQ34571228-E3952843-204A-445F-93E3-A2E152744FB8Q34771486-93B9DA3E-C2EC-4A29-B21A-669CEEEBA56FQ35014979-7EE1F030-BB32-4349-8E35-FAAA35CB0BDFQ35043774-B98DB9B0-3C40-46F1-B6C2-D2BCC6FF48B2Q35182250-3E0CB1D5-3971-489D-8F87-11F23448B26FQ35624610-487EDAFD-0D69-49BA-B8EE-45BAAEDEA2E3Q35625075-AB39187F-6983-4643-8C1F-8F35B36047E9Q36015119-B997D7A4-2950-42EC-8146-E7F66A8728E1Q36024353-48D70997-7248-4F40-B73B-86BB07923AB8Q36112324-30AD3FC2-867A-4C18-998A-C4F1BC978123Q36128887-B3824887-4E4E-4DC0-A102-73B4FFFF6A29Q36309300-83683D99-3D75-4F1D-BF3D-52C891B560CAQ36345024-FAC9E893-38F7-4C27-8986-3650EFB6C828Q36557975-FFC9F6EB-AC23-4431-9A57-07EA77930013Q36632303-049500CD-6269-48C4-945A-C6D4F47B14E0Q36729977-CC48FAD8-F6E0-4435-BB60-425FC7F1576CQ36907082-26859C2D-3FC4-4E61-87B1-69A2D87050DAQ37096428-6D8F9487-8D41-4223-B693-32536329DC95
P2860
Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Patient reporting of suspected ...... and international experience.
@ast
Patient reporting of suspected ...... and international experience.
@en
type
label
Patient reporting of suspected ...... and international experience.
@ast
Patient reporting of suspected ...... and international experience.
@en
prefLabel
Patient reporting of suspected ...... and international experience.
@ast
Patient reporting of suspected ...... and international experience.
@en
P2093
P2860
P1476
Patient reporting of suspected ...... e and international experience
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.2006.02746.X
P407
P577
2007-02-01T00:00:00Z